Rchr
J-GLOBAL ID:201801010577767177   Update date: Aug. 06, 2025

Yohei Mikami

ミカミ ヨウヘイ | Yohei Mikami
Affiliation and department:
Job title: Associate Professor
Research field  (1): Gastroenterology
Research keywords  (4): Neuroimmunology ,  Tissue regeneration and fibrosis ,  Mucosal immunology ,  Inflammatory bowel disease
Research theme for competitive and other funds  (8):
  • 2024 - 2027 Elucidation of Neuro-Immune Interactions in Inflammatory Bowel Disease and Development of Novel Treatments Using New Neural Tracing Methods
  • 2024 - 2027 Comprehensive Understanding of Host Immune-Gut Microbiota Interactions underlying Autoimmune Diseases
  • 2023 - 2026 Elucidation of the gut-liver-brain axis in response to host-invading bacteria and the development of treatments for gastrointestinal immune diseases
  • 2021 - 2024 炎症性組織レジリエンスと組織障害エントロピーの統合的理解と炎症収束学の創成
  • 2021 - 2024 Elucidation of the entropy of tissue damage in digestive organs and development of new therapeutic approaches
Show all
Papers (132):
  • Sakamoto K., Okabayashi K., Seishima R., Shigeta K., Kiyohara H., Mikami Y., Kanai T., Kitagawa Y. Radiomics prediction of surgery in ulcerative colitis refractory to medical treatment. Techniques in Coloproctology. 2025. 29. 1. 113
  • Shih, HY, Sciumè, G., Mikami, Y. Epigenomic control of immunity: from mechanisms to therapeutic targets in inflammatory bowel diseases. INTERNATIONAL IMMUNOLOGY. 2025
  • Shigehara A., Kiyohara H., Teratani T., Nakamoto N., Mikami Y., Kanai T. Gut Microbiota and Interorgan Communication among the Gut, Brain, and Beyond. Internal medicine (Tokyo, Japan). 2025
  • Matsuoka, K., Motoya, S., Yamamoto, T., Matsuura, M., Fujii, T., Shinzaki, S., Mikami, Y., Arai, S., Oshima, J., Endo, Y., et al. Post-marketing surveillance of tofacitinib in patients with ulcerative colitis in Japan: a final report of safety and effectiveness data. JOURNAL OF GASTROENTEROLOGY. 2025. 60. 8. 979-989
  • Yamane, T., Masaoka, T., Ishii, C., Masuoka, H., Suda, W., Kurokawa, S., Kishimoto, T., Mikami, Y., Fukuda, S., Kanai, T. Factors Contributing to the Efficacy of Fecal Microbiota Transplantation for Diarrhea-Dominant Functional Bowel Disorders. DIGESTION. 2025. 1-11
more...
MISC (11):
  • Matsuoka K., Yamazaki H., Nagahori M., Kobayashi T., Omori T., Mikami Y., Fujii T., Shinzaki S., Saruta M., Matsuura M., et al. Correction: Association of ulcerative colitis symptom severity and proctocolectomy with multidimensional patient-reported outcomes: a cross-sectional study(Journal of Gastroenterology, (2023), 58, (751-765), 10.1007/s00535-023-02005-7). Journal of Gastroenterology. 2024. 59. 7. 644-646
  • Niemi M.E.K., Karjalainen J., Liao R.G., Neale B.M., Daly M., Ganna A., Pathak G.A., Andrews S.J., Kanai M., Veerapen K., et al. Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x). Nature. 2023. 621. 7977. E7-E26
  • Masahiro Kanai, Shea J. Andrews, Mattia Cordioli, Christine Stevens, Benjamin M. Neale, Mark Daly, Andrea Ganna, Gita A. Pathak, Akiko Iwasaki, Juha Karjalainen, et al. A second update on mapping the human genetic architecture of COVID-19. Nature. 2023. 621. 7977. E7-E26
  • Matsuoka K., Fujii T., Okamoto R., Yamada A., Kunisaki R., Matsuura M., Watanabe K., Shiga H., Takatsu N., Bamba S., et al. Correction: Characteristics of adult patients newly diagnosed with Crohn’s disease: interim analysis of the nation-wide inception cohort registry study of patients with Crohn’s disease in Japan (iCREST-CD) (Journal of Gastroenterology, (2022), 57, 11, (867-878), 10.1007/s00535-022-01907-2). Journal of Gastroenterology. 2023. 58. 6. 602-603
  • Ishige T., Shimizu T., Watanabe K., Arai K., Kamei K., Kudo T., Kunisaki R., Tokuhara D., Naganuma M., Mizuochi T., et al. Correction to: Expert consensus on vaccination in patients with inflammatory bowel disease in Japan (Journal of Gastroenterology, (2023), 58, 2, (135-157), 10.1007/s00535-022-01953-w). Journal of Gastroenterology. 2023. 58. 4. 431-432
more...
Lectures and oral presentations  (1):
  • RESIDENT NON-CLASSICAL MONOCYTES ARE CRITICALLY IMPORTANT FOR TISSUE DESTRUCTION IN ARTHRITIS
    (ANNALS OF THE RHEUMATIC DISEASES 2017)
Education (1):
  • 2008 - 2012 Keio University Graduate School of Medicine
Professional career (1):
  • PhD (Medicine) (Keio University)
Work history (8):
  • 2023/05 - 現在 Keio University Hospital IBD Centre Vice-Director
  • 2021/10 - 現在 Keio University School of Medicine Division of Gastroenterology and Hepatology, Department of Internal Medicine, Associate Professor
  • 2021/04 - 2021/09 Keio University School of Medicine Division of Gastroenterology and Hepatology, Department of Internal Medicine, Assistant Professor
  • 2020/10 - 2021/03 Keio University School of Medicine Division of Gastroenterology and Hepatology, Department of Internal Medicine, Assistant Professor
  • 2020/04 - 2020/09 Keio University School of Medicine Division of Gastroenterology and Hepatology, Department of Internal Medicine, Assistant Professor
Show all
Awards (6):
  • 2025/06 - Kitasato Award
  • 2021/12 - 日本免疫学会研究奨励賞
  • 2021/01 - 慶應医学賞 ライジング・スター賞
  • 2018/12 - 第55回日本消化器免疫学会総会 奨励賞
  • 2016/10 - NIH Group Merit Award
Show all
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page